Terms: = Prostate cancer AND ABI1, E3B1, 10006, SSH3BP1, ABI-1
3 results:
1. Abiraterone acetate plus prednisone in non-metastatic biochemically recurrent castration-naïve prostate cancer.
Spetsieris N; Boukovala M; Alafis I; Davis J; Zurita A; Wang X; Tu SM; Chapin BF; Aparicio A; Corn P; Wang J; Subudhi SK; Araujo J; Papadopoulos J; Pruitt L; Weldon JA; Logothetis CJ; Efstathiou E
Eur J Cancer; 2021 Nov; 157():259-267. PubMed ID: 34536949
[TBL] [Abstract] [Full Text] [Related]
2. abi1 loss drives prostate tumorigenesis through activation of EMT and non-canonical WNT signaling.
Nath D; Li X; Mondragon C; Post D; Chen M; White JR; Hryniewicz-Jankowska A; Caza T; Kuznetsov VA; Hehnly H; Jamaspishvili T; Berman DM; Zhang F; Kung SHY; Fazli L; Gleave ME; Bratslavsky G; Pandolfi PP; Kotula L
Cell Commun Signal; 2019 Sep; 17(1):120. PubMed ID: 31530281
[TBL] [Abstract] [Full Text] [Related]
3. [The role of EGF receptor-dependent e3b1/abi1 protein as a tumor suppressor protein in malignant tumors].
Jenei V; Jakus J
Orv Hetil; 2005 Jun; 146(24):1293-9. PubMed ID: 16025998
[TBL] [Abstract] [Full Text] [Related]
